Belite Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	-	88.16	42.09	17.34	25.62
Cash & Short-Term Investments	-	88.16	42.09	17.34	25.62
Cash Growth	-	109.45%	142.67%	-32.30%	-
Other Receivables	-	0.84	0	-	-
Receivables	-	0.84	0	-	-
Prepaid Expenses	-	0.92	0.7	0.06	0.01
Other Current Assets	111.27	0.03	0.02	0.02	0.04
Total Current Assets	111.27	89.94	42.81	17.43	25.67
Property, Plant & Equipment	-	1.3	1.35	0.09	0.05
Long-Term Deferred Charges	-	-	-	0.82	-
Other Long-Term Assets	4.55	3.4	0.12	0.01	0.03
Total Assets	115.82	94.64	44.27	18.35	25.74
Accrued Expenses	-	3.18	1.83	1.54	0.97
Current Portion of Leases	-	0.31	0.2	-	-
Other Current Liabilities	3.62	0.15	0.07	0.1	0.01
Total Current Liabilities	3.62	3.63	2.1	1.64	0.97
Long-Term Leases	-	0.58	0.67	-	-
Total Liabilities	3.62	4.21	2.77	1.64	0.97
Common Stock	112.2	0	0	0	0
Additional Paid-In Capital	-	162.31	81.76	12.33	10.56
Retained Earnings	-	-71.5	-39.87	-27.22	-17.56
Comprehensive Income & Other	-	-0.37	-0.39	-0.2	-0.04
Total Common Equity	112.2	90.43	41.5	-15.09	-7.04
Shareholders' Equity	112.2	90.43	41.5	16.71	24.77
Total Liabilities & Equity	115.82	94.64	44.27	18.35	25.74
Total Debt	-	0.89	0.87	-	-
Net Cash (Debt)	-	87.27	41.22	17.34	25.62
Net Cash Growth	-	111.70%	137.68%	-32.30%	-
Net Cash Per Share	-	3.28	2.06	1.81	2.91
Filing Date Shares Outstanding	30.69	29.15	24.9	10.27	9.57
Total Common Shares Outstanding	30.69	29.15	24.9	10.27	9.57
Working Capital	107.65	86.31	40.7	15.8	24.7
Book Value Per Share	3.66	3.10	1.67	-1.47	-0.74
Tangible Book Value	112.2	90.43	41.5	-15.09	-7.04
Tangible Book Value Per Share	3.66	3.10	1.67	-1.47	-0.74
Machinery	-	0.49	0.45	0.14	0.09
Leasehold Improvements	-	0.19	0.19	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.